Colestid
FDA Approves New Kynamro for Inherited Cholesterol Disorder »
"The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemi"...
Read the FDA Approves New Kynamro for Inherited Cholesterol Disorder article »
Colestid
PATIENT INFORMATION
COLESTID (colestipol) Tablets may be larger than pills you have taken before. If you have had swallowing problems or choking with food, liquids or other tablets or capsules in the past, you should discuss this with your doctor before taking COLESTID (colestipol) Tablets.
It is important that you take COLESTID (colestipol) Tablets correctly:
- Always take one tablet at a time and swallow promptly.
- Swallow each tablet whole. Do not cut, crush, or chew the tablets.
- COLESTID (colestipol) Tablets must be taken with water or another liquid that you prefer. Swallowing the tablets will be easier if you drink plenty of liquid as you swallow each tablet.
Difficulty swallowing and temporary obstruction of the esophagus (the tube between your mouth and stomach) have been rarely reported in patients taking COLESTID (colestipol) Tablets. If a tablet does get stuck after you swallow it, you may notice pressure or discomfort. If this happens to you, you should contact your doctor. Do not take COLESTID (colestipol) Tablets again without your doctor's advice.
If you are taking other medications, you should take them at least one hour before or four hours after taking COLESTID (colestipol) Tablets.
Last reviewed on RxList: 4/9/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Colestid Information
Colestid - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cholesterol Management
Tips to keep it under control.






